InvestorsHub Logo
icon url

paulsw42

03/29/16 11:36 AM

#35139 RE: Endofanera #35138

April is going to be a good month.
icon url

BIGKAHUNA57

03/29/16 1:38 PM

#35144 RE: Endofanera #35138

Great find. Good article because it provides specific subject matter about costs associated with robotic surgery. Of course the source is ISRG, and they would want a broader conversation regarding associated costs beyond the cost of robotic surgery to further cost justify the expense using the
da Vinci. Bonus: Titan is specifically mentioned at the end of the article.

Thank you for finding that article.

Regards,
BK
icon url

posilock

03/29/16 1:59 PM

#35145 RE: Endofanera #35138

I like this part the most makes Titan look good. And Transertix not so good.

but two new surgical robotic systems are expected to come to the market this year. Those systems are Titan Medical’s SPORT system, which is for general abdominal, gynecologic, urologic and colorectal procedures, and TransEnterix’s SurgiBot robotic system, which doesn’t have any known indications yet.